Study Design
Preclinical study examining the role of microcrystal deposits in PKD cystogenesis and the protective effect of citrate supplementation in PKD animal models.
Intervention
Citrate supplementation in drinking water of PKD mice. Compared crystal formation and cyst development with and without citrate.
Key Results
Crystal-Cyst Connection: Confirmed
Microcrystal deposits in kidney tubules trigger new cyst formation. PKD kidneys are more susceptible to crystal-induced damage.
Citrate Protection: Effective
Citrate supplementation prevented crystal formation and reduced cyst development in PKD models.
Mechanism: Tubular injury
Crystals cause tubular cell injury and dedifferentiation, creating conditions that promote cystogenesis in genetically susceptible kidneys.
Significance
This paper provides the scientific rationale for including citrate in KetoCitra. PKD patients are prone to kidney stones and microcrystal formation, which can trigger new cysts. By supplementing with citrate (a natural crystal inhibitor), this damaging cycle can be interrupted. Combined with the BHB component targeting cyst growth directly, the dual-action approach of KetoCitra addresses two distinct pathological mechanisms.